1. Home
  2. ORMP vs STIM Comparison

ORMP vs STIM Comparison

Compare ORMP & STIM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Oramed Pharmaceuticals Inc.

ORMP

Oramed Pharmaceuticals Inc.

N/A

Current Price

$4.69

Market Cap

170.3M

Sector

Health Care

ML Signal

N/A

Logo Neuronetics Inc.

STIM

Neuronetics Inc.

N/A

Current Price

$2.97

Market Cap

120.4M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
ORMP
STIM
Founded
2002
2003
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Medical/Dental Instruments
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
170.3M
120.4M
IPO Year
2010
2018

Fundamental Metrics

Financial Performance
Metric
ORMP
STIM
Price
$4.69
$2.97
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$3.00
AVG Volume (30 Days)
198.5K
1.2M
Earning Date
05-14-2026
05-05-2026
Dividend Yield
6.51%
N/A
EPS Growth
412.50
57.25
EPS
2.76
N/A
Revenue
$2,000,000.00
$52,776,000.00
Revenue This Year
N/A
$11.10
Revenue Next Year
N/A
$11.92
P/E Ratio
$1.68
N/A
Revenue Growth
49.25
N/A
52 Week Low
$2.09
$0.80
52 Week High
$5.47
$3.44

Technical Indicators

Market Signals
Indicator
ORMP
STIM
Relative Strength Index (RSI) 46.12 50.27
Support Level $3.91 $2.67
Resistance Level $5.10 N/A
Average True Range (ATR) 0.20 0.20
MACD -0.07 -0.05
Stochastic Oscillator 8.70 22.88

Price Performance

Historical Comparison
ORMP
STIM

About ORMP Oramed Pharmaceuticals Inc.

Oramed Pharmaceuticals Inc is a pharmaceutical company that is engaged in the research and development of pharmaceutical solutions with a technology platform that allows for the oral delivery of therapeutic proteins. The company has developed an oral dosage form intended to withstand the harsh environment of the gastrointestinal tract and effectively deliver active insulin or other proteins. Its product pipeline includes ORMD-0801 for Diabetes, ORMD-0801 for NASH, and ORMD 0901.

About STIM Neuronetics Inc.

Neuronetics Inc a commercial-stage medical technology company focused on designing, developing, and marketing products that improve the quality of life for patients who suffer from psychiatric disorders. Its first commercial product, the NeuroStar Advance Therapy System, is a non-invasive and non-systemic office-based treatment that uses transcranial magnetic stimulation, or TMS, to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. The company designed the NeuroStar Advance Therapy as a non-invasive therapeutic alternative to treat patients who suffer from MDD and to address the existing treatment options. The company operates in two segments: medical devices and clinic services.

Share on Social Networks: